Перейти к основной навигации
Перейти к поиску
Перейти к основному содержанию
Сортировать по:
Keyphrases
16S rRNA Gene Sequencing
16%
Acute Lymphoblastic Leukemia
16%
Adaptive Immune Response
16%
Autoantibodies
16%
Autoimmune Disease
33%
Autoimmune Lymphoproliferative Syndrome
16%
Autoimmune Manifestations
16%
B Cells
16%
CD4-CD8 Ratio
16%
Clinical Entity
16%
Collaborative Research
16%
Combined Analysis
100%
Diagnostic Criteria
16%
Disease Groups
16%
DN T Cells
100%
Double-negative T Cells
100%
Fecal Microbiome
16%
First Degree Relatives
16%
Flow Cytometry
16%
Gut Microbiota
33%
Hematological Diseases
100%
Hodgkin Lymphoma
16%
Immune System
16%
Immune-mediated Disorders
16%
Immunopathogenesis
16%
Immunophenotyping
16%
Immunosurveillance
16%
Juvenile Idiopathic Arthritis
33%
Lymphadenopathy
16%
Lymphoblastic Leukemia
16%
Lymphoma
50%
Lymphoproliferative Disorders
100%
Malignant Lymphoproliferative Disorders
16%
Metagenomic Approach
16%
Microbiome
100%
Microbiome Study
16%
Mild Disease
16%
Multi-parameter
16%
Neoplastic Disease
16%
Non-Hodgkin Lymphoma
16%
Nonmalignant
16%
Oncological Disorders
16%
Ontogenesis
16%
Pediatric
33%
Pediatric Patients
100%
Pediatric Systemic Lupus Erythematosus
33%
Phenotypic Characterization
16%
Post-infection
16%
Potential Relationships
16%
Prospective Cross-sectional Study
16%
Pulmonary Disease
16%
Reactive Arthritis
16%
Reactive Lymphadenopathy
16%
Rheumatic Disorders
100%
Salivary Microbiome
16%
Same-gender
16%
Shotgun Proteomics
16%
Systemic Lupus Erythematosus Patient
16%
T Lymphocyte Subsets
16%
Tumoral
16%
Unconventional T Cells
16%
Immunology and Microbiology
Adaptive Immune System
25%
Autoantibodies
25%
Autoimmune Disease
50%
Autoimmune Lymphoproliferative Syndrome
25%
Autoimmunity
25%
B Cell
25%
CD4
25%
CD8
25%
Gene Sequence
25%
Gut Microbiome
50%
Immune System
25%
Immunopathogenesis
25%
Immunosurveillance
25%
Juvenile Idiopathic Arthritis
50%
Lymphadenopathy
50%
Lymphoproliferative Disorders
75%
Metagenomics
25%
Microbiome
100%
Ontogeny
25%
Reactive Arthritis
25%
Ribosomal RNA
25%
Systemic Lupus Erythematosus
50%
T Cell
100%
T Lymphocyte Subpopulation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
16%
Autoantibodies
16%
Autoimmune Disease
33%
Autoimmune Lymphoproliferative Syndrome
16%
CD8 Antigen
16%
Cross-Sectional Study
16%
Diseases
33%
Flow Cytometry
16%
Hematologic Disease
100%
Hodgkin Disease
16%
Immunopathogenesis
16%
Juvenile Rheumatoid Arthritis
33%
Lung Disease
16%
Lymphadenopathy
33%
Lymphatic Leukemia
16%
Lymphoproliferative Disease
66%
Microbiome
100%
Neoplasm
16%
Nonhodgkin Lymphoma
16%
Reactive Arthritis
16%
RNA 16S
16%
Systemic Lupus Erythematosus
33%